ProPhase Labs, Inc. Common Stock (DE) (PRPH) Stock Price, Quote & AI Analysis

Live PRPH stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for ProPhase Labs, Inc. Common Stock (DE).

TradeVae provides AI-driven analysis and real-time market intelligence for ProPhase Labs, Inc. Common Stock (DE) (PRPH), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

PRPH
ProPhase Labs, Inc. Common Stock (DE)
real-time
$0.00 +0.00 (+0.00%)
Open
0.072800
High
0.087900
Low
0.072800
Volume
120,311
VWAP
-
Market Cap
$11,743,698.65
52W Range
$0.07 - $0.93
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 30, 2026 Q4
After Hours
EPS Estimate: $-0.1224
Revenue Estimate: $9,863,400.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

ProPhase Labs, Inc. Common Stock (DE)'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

ProPhase Labs, Inc. Common Stock (DE) Overview

Company information

Company Overview

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.

Company Details
Market Cap
$4.02M
Shares Outstanding
46,179,000
Weighted Shares Outstanding
41,541,205
CEO
Ted William Karkus
Address
711 STEWART AVE, SUITE 200, NEW YORK, NY, 11530
Phone
(215) 345-0919
Employees
96
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS
Listed
Feb 1995

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

ProPhase Labs, Inc. Common Stock (DE) Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...